Panasonic HD Launches Verification of Automated iPS Cell Production Technology

Panasonic Holdings Corporation has officially commenced verification tests for its newly developed fully automated induced pluripotent stem cell tree establishment technology. The demonstration is currently underway at the my iPS Project joint research laboratory located within Nakanoshima Qross in Osaka, Japan, and is scheduled to run until March 2027.

In a strategic partnership with the CiRA Foundation, which is short for the Center for iPS Cell Research and Application Foundation at Kyoto University, Panasonic HD has successfully demonstrated that its automated equipment can reproduce the intricate tree establishment process. Historically, this highly delicate procedure required the precise, hands-on manual expertise of experienced technicians.

The global market for induced pluripotent stem cells has seen exponential growth, driven by advancements in regenerative medicine and drug discovery. However, the reliance on manual cultivation by skilled experts has consistently created bottlenecks in terms of production volume, high operational costs, and quality consistency. By introducing clinical-grade automation, this project aims to lower the hurdles for widespread medical application.

During this multi-year verification phase, Panasonic HD will install the equipment directly into a working laboratory environment to validate its practical utility. By simulating conditions closely matching actual manufacturing sites, the company focuses on identifying and solving technical challenges to ensure long-term, stable operation and process optimization. The ultimate goal is to standardize high-quality, high-throughput cell production, accelerating the timeline for affordable, personalized regenerative medicine on a global scale.